Genomic damage in patients with type-2 diabetes mellitus

D N Binici1, A Karaman, M Coşkun

  • 1Department of Internal Medicine, Erzurum Training and Research Hospital, Erzurum, Turkey.

Genetic Counseling (Geneva, Switzerland)
|September 17, 2013
PubMed

Insights

Type-2 diabetes mellitus (DM2) is linked to increased DNA damage, specifically higher frequencies of sister chromatid exchange (SCE) and micronuclei (MN). This genomic instability in DM2 patients may stem from hyperglycemia-induced oxidative stress.

Area of Science:

  • Genetics
  • Endocrinology
  • Molecular Biology

Background:

  • DNA damage is implicated in the pathogenesis of type-2 diabetes mellitus (DM2) and its complications.
  • Various in vitro assays exist for measuring DNA damage.

Purpose of the Study:

  • To investigate the frequency of sister chromatid exchange (SCE) and micronuclei (MN) in DM2 patients compared to healthy controls.

Main Methods:

  • Blood cell cultures from 50 DM2 patients and 30 healthy controls were analyzed.
  • Sister chromatid exchange (SCE) and micronuclei (MN) tests were performed.
  • Demographic and clinical data, including HbA1c levels, were collected.

Main Results:

  • DM2 patients exhibited significantly higher frequencies of SCE (7.11 +/- 1.14) compared to controls (4.96 +/- 0.92) (p < 0.001).
  • SCE frequency positively correlated with HbA1c levels (p < 0.05) but not with diabetes duration.
  • A significant increase in MN frequency was observed in DM2 patients (3.45 +/- 1.01 per 1000 cells) versus controls (1.79 +/- 0.67 per 1000 cells) (p < 0.001).
  • No significant correlation was found between MN frequency and diabetes duration or HbA1c levels.

Conclusions:

  • DM2 is characterized by genomic instability, evidenced by elevated SCE and MN frequencies.
  • Hyperglycemia-induced oxidative stress is a potential underlying mechanism for increased DNA damage in DM2.
  • These findings highlight the role of DNA damage in DM2 pathogenesis and complications.

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...